FDA Approves Genentech’s Alecensa for Early-Stage ALK-Positive NSCLC
Genentech says the approval makes the drug the first ALK inhibitor for patients with ALK-positive, early-stage non-small cell lung cancer who have undergone surgery.
Genentech says the approval makes the drug the first ALK inhibitor for patients with ALK-positive, early-stage non-small cell lung cancer who have undergone surgery.
The FDA approved osimertinib (Tagrisso) with platinum-based chemotherapy for certain patients with non-small cell lung cancer (NSCLC).
The FDA approved the first cell-based gene therapies for the treatment of sickle cell disease in patients 12 years and older. One therapy, Casgevy, is the first FDA-approved treatment to utilize the genome editing technology CRISPR/Cas9
The FDA granted Empatica 510(k) clearance for two new digital biomarkers for its Empatica Health Monitoring Platform: pulse and respiratory rate.
Read MoreThe device is designed to improve insomnia by delivering a small electrical pulse to the head for 30 minutes before bed.
Read MoreThe FDA has cleared a contactless bedside device that uses macro- and micro-motion to remotely monitor vital signs in patients with chronic conditions.
Read MoreThe FDA approved Moderna’s updated COVID-19 vaccine (Spikevax) for ages 12 years and above, and issued emergency use authorization for children age 6 months through 11 years old.
Read MoreThe US Food and Drug Administration has granted BodiMetrics 510k clearance for its circul pro ring as a pulse oximeter.
Read MoreThe US FDA has granted 510(k) clearance to the alveoair digital spirometer, according to a press release by the manufacturer, alveofit.
Read MoreLivaNova has received FDA 510(k) clearance for its Essenz In-Line Blood Monitor, which provides continuous measurement of blood parameters to perfusionists throughout cardiopulmonary bypass procedures.
Read MoreThe wearable, wireless monitoring solution provides a real-time view of patients while monitoring dual vector respiration rate, SpO2, and pulse rate continuously.
Read MoreGE HealthCare’s Portrait Mobile platform enables real-time continuous monitoring with a personalized view of the patient’s vitals while keeping patients mobile during critical recovery periods, especially after surgery or discharge from the intensive care unit.
Read MoreA remote monitoring platform called AeviceMD that includes a smart, wearable stethoscope has received clearance from the US FDA, according to manufacturer Aevice Health.
Read MoreThe US Food and Drug Administration approved a 3-milligram naloxone hydrochloride nasal spray for over-the-counter, nonprescription use for the emergency treatment of known or suspected opioid overdose.
Read MoreBeyfortus is the first preventive option approved to protect a broad infant population, including those born healthy at term, preterm, or with specific health conditions that make them vulnerable to severe RSV disease.
Read More